A Study of NX-1607 in Adults With Advanced Malignancies

计划入组 345 人 · 首次发布于 2021 年 11 月 4 日

HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma

计划入组 18 人 · 首次发布于 2015 年 2 月 24 日

A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

首次发布于 2016 年 5 月 18 日

Proto-oncogene Protein c-met Inhibitors (Pfizer)

AB&B BIO-TECH-B

B R B Software Systems Inc

United States

VIGONVITA-B

Nurix Therapeutics Appoints Anil Kapur to Board, Plans Pivotal Trial for NX-5948

Nurix Therapeutics Pipeline Review: BTK Degraders and Targeted Protein Degradation Advance in B-Cell Malignancies

Nurix Therapeutics Presents Promising BTK Degrader Data at ASH 2024